400 related articles for article (PubMed ID: 14188465)
1. EXPERIMENTAL CHEMOTHERAPY STUDIES. IV. THE PROTECTIVE ACTION OF MERCAPTOALKYLAMINES AGAINST ALKYLATING AGENTS.
RUTMAN RJ; LEWIS FS; PRICE CC
Cancer Res; 1964 May; 24():626-33. PubMed ID: 14188465
[No Abstract] [Full Text] [Related]
2. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
RUTMAN RJ
Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466
[No Abstract] [Full Text] [Related]
3. EXPERIMENTAL STUDY OF OLIVOMYCIN, AN ANTITUMOUR ANTIBIOTIC.
CHORIN VA; ROSSOLIMO OK; GOLDBERG LE; STANISLAVSKAYA MS; BLUMBERG NA; VERTOGRADOVA TP
Acta Unio Int Contra Cancrum; 1964; 20():289-90. PubMed ID: 14151910
[No Abstract] [Full Text] [Related]
4. THE TREATMENT OF CARCINOMA IN DOGS' BLADDERS WITH CYTOTOXIC DRUGS.
BOYLAND E; KINDER CH; WILLIAMS K
Invest Urol; 1965 Mar; 2():446-52. PubMed ID: 14261785
[No Abstract] [Full Text] [Related]
5. EFFECT OF ADMINISTRATION OF THE ENZYME GLUTAMINASE ON THE GROWTH OF CANCER CELLS.
GREENBERG DM; BLUMENTHAL G; RAMADAN ME
Cancer Res; 1964 Jul; 24():957-63. PubMed ID: 14195348
[No Abstract] [Full Text] [Related]
6. A STUDY OF COMPARATIVE CHEMICAL AND BIOLOGICAL ACTIVITIES OF ALKYLATING AGENTS.
BARDOS TJ; DATTA-GUPTA N; HEBBORN P; TRIGGLE DJ
J Med Chem; 1965 Mar; 8():167-74. PubMed ID: 14335145
[No Abstract] [Full Text] [Related]
7. [TEST OF THE ACTION OF SOME NITROGEN MUSTARD DERIVATIVES ON STICKER'S LYMPHOSARCOMA].
ZEZZANETO L; SOERENSEN B; SALIBA AM; GRECCHI R
Rev Bras Cir; 1963 Aug; 46():101-8. PubMed ID: 14097899
[No Abstract] [Full Text] [Related]
8. POTENTIAL ANTICANCER AGENTS. LXXX. ALKYLATING AGENTS RELATED TO PHENYLALANINE MUSTARD. VI. ENANTIOMERIC META-PHENYLALANINE MUSTARDS.
GRAM HF; BERRIDGE BJ; ACTON EM; GOODMAN L
J Med Chem; 1963 Jan; 6():85-7. PubMed ID: 14174040
[No Abstract] [Full Text] [Related]
9. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. 3. TOXICITY DATA ON MONKEYS AND DOGS.
SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1017+. PubMed ID: 14278900
[No Abstract] [Full Text] [Related]
10. ANTITUMOR EFFECT OF OLIVOMYCIN COMBINED WITH VARIOUS SYNTHETIC CYTOTOXIC DRUGS.
ROSSOLIMO OK; LEPESHKINA GN
Fed Proc Transl Suppl; 1964; 23():484-6. PubMed ID: 14185884
[No Abstract] [Full Text] [Related]
11. CHEMOTHERAPY OF BRAIN TUMORS. I. TRANSPLANTED MURINE EPENDYMOBLASTOMAS.
SOLOWAY AH; MARK VH; DUKAT EG; KJELLBERG RN
Cancer Chemother Rep; 1964 Mar; 36():1-4. PubMed ID: 14152269
[No Abstract] [Full Text] [Related]
12. HISTOLOGICAL AND HISTOCHEMICAL DATA ON THE PROCESS OF REGRESSION OF EXPERIMENTAL TUMOURS INDUCED BY ALKYLATING AGENTS.
PRESNOV MA
Acta Unio Int Contra Cancrum; 1964; 20():126-30. PubMed ID: 14151866
[No Abstract] [Full Text] [Related]
13. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. II. THERAPEUTIC ACTIVITIES OF ALKYLATING AGENTS AND REFERENCE COMPOUNDS AGAINST VARIOUS TUMOR SYSTEMS.
SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:403+. PubMed ID: 14278902
[No Abstract] [Full Text] [Related]
14. [EXPERIMENTAL STUDIES ON THE ANTITUMOR EFFECT OF OLIVOMYCIN IN ASSOCIATION WITH SOME SYNTHETIC CYTOSTATIC PREPARATIONS].
ROSSOLIMO OK; LEPESHKINA GN
Antibiotiki; 1963 Apr; 8():332-6. PubMed ID: 14072480
[No Abstract] [Full Text] [Related]
15. CLINICAL EVALUATION OF URACIL MUSTARD.
WILLIAMS HM
Cancer Chemother Rep; 1963 Oct; 32():73-6. PubMed ID: 14088838
[No Abstract] [Full Text] [Related]
16. CYTOTOXIC ACTIVITY COMPARED WITH PHOTOMETRIC MEASUREMENTS OF SELECTED ALKYLATING AGENTS.
SANDERSON RP; MCKENNA JM; BLAKEMORE WS
Nature; 1965 Jan; 205():479-81. PubMed ID: 14265292
[No Abstract] [Full Text] [Related]
17. CLINICAL STUDIES OF DICHLOROMETHOTREXATE (NSC 29630).
FREI E; SPURR CL; BRINDLEY CO; SELAWRY O; HOLLAND JF; RALL DP; WASSERMAN LR; HOOGSTRATEN B; SHNIDER BI; MCINTYRE OR; MATTHEWS LB; MILLER SP
Clin Pharmacol Ther; 1965; 6():160-71. PubMed ID: 14288185
[No Abstract] [Full Text] [Related]
18. GROWTH INHIBITION OF A SPECTRUM OF TRANSPLANTED MOUSE TUMORS BY COMBINATIONS OF INHIBITORS OF NUCLEIC ACID BIOSYNTHESIS AND ALKYLATING AGENTS.
BOOTH BA; SARTORELLI AC
Cancer Res; 1963 Dec; 23():1762-8. PubMed ID: 14082870
[No Abstract] [Full Text] [Related]
19. [EXPERIMENTAL AND CLINICAL FINDINGS ON THE THERAPEUTIC USE OF A NEW ALKYLATING DRUG: URACIL MUSTARD].
BALLERINI G; CASTOLDI G; RICCI N; TENZE L
Clin Ter; 1965 Jan; 32():49-61. PubMed ID: 14262587
[No Abstract] [Full Text] [Related]
20. SYNTHESIS OF TUMOR INHIBITION BY A TRYTOPHAN MUSTARD.
BARCLAY RK; PHILLIPPS MA; PERRI GC; SUGIURA K
Cancer Res; 1964 Sep; 24():1324-30. PubMed ID: 14221790
[No Abstract] [Full Text] [Related]
[Next] [New Search]
